Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years’ outcome from the Halt trial

Table 3 Surgical re-interventions (6/124, 4.8%) between 12 and 24 months post procedure

Pt	Treated fibroids ^a	Symp severity ^b		HRQL ^c		Reintervention	Pathology
		Baseline	12 mo	Baseline	12 mo
1	6 Subserosals 5.6; 4.4; 1.5; 3.6; 1.9; 3.0	53.1	28.1	46.6	89.7	Hysterectomy at 16.5 months	Multiple myomas ranging from 0.4 to 4.7 cm; focally irregular endo-myometrial junction
	2 Intramurals 4.8: 4.7
	1 Subserosal/Intramural 2.7
2	4 Intramurals 5.2; 1.8; 1.1; 1.8	68.8	28.1	10.3	82.8	Hysteroscopic myomectomy by resection at 15 months	No pathology
3	3 Subserosals 5.0; 1.3; 1.9	78.1	43.8	20.7	51.7	Hysterectomy at 14 months	Multiple myomas ranging from 0.6 to 3.4 cm; focal adenomyosis
3	1 Intramural 1.8	78.1	43.8	20.7	51.7	Hysterectomy at 14 months
4	1 Intramural 2.0	62.5	28.1	10.3	60.3	Supracervical hysterectomy at 23 months	Only morcellated tissue available. Findings: adenomyosis, leiomyomata, proliferative endometrium
	1 Submucosal 2.0 1
	Undefined 1.9
5	5 Intramurals 2.7; 2.7; 2.6; 8.5; 6.7	75.0	56.3	17.2	28.4	Hysteroscopic myomectomy by resection at 16 months	Focal degenerative changes and features suggestive of polyp
5	1 Undefined 3.2	75.0	56.3	17.2	28.4	Hysteroscopic myomectomy by resection at 16 months	Focal degenerative changes and features suggestive of polyp
6	1 Intramural 2.0	53.1	62.5	37.1	43.1	Hysterectomy at 23.5 months	Adenomyosis; multiple myomas ranging in size from 0.4 cm to 1.2 cm
	1 Subserosal 2.0

^a Information includes the number of each type of treated fibroid and the maximum diameter (cm) of each fibroid.
^b Mean transformed symptom severity scores.
^c Mean transformed health-related quality-of-life scores.

ISSN: 1477-7525